Literature DB >> 19102377

Occult hepatitis B virus infection in chronic hemodialysis patients in Korea.

Geum-Youn Gwak1, Wooseong Huh, Dong Ho Lee, Byung-Hoon Min, Kwang Cheol Koh, Jae J Kim, Ha-Young Oh.   

Abstract

BACKGROUND/AIMS: Occult HBV infection that is serum HBsAg negative but HBV DNA positive is thought to be a contributing factor to ongoing HBV transmission within hemodialysis units. In the present study, the prevalence of occult HBV infection was investigated in patients on chronic hemodialysis in Korea, an endemic region for HBV.
METHODOLOGY: Eighty-three patients undergoing maintenance hemodialysis at Samsung Medical Center, Seoul, South Korea were included. Serum samples were obtained from all patients. Testing for HBsAg, anti-HBs and anti-HBc was performed by an electrochemiluminescence immunoassay. HBV DNA was detected by the nested PCR method.
RESULTS: Among the 83 patients, 4 (4.8%) were HBsAg positive and HBV DNA positive. The remaining 79 patients were confirmed HBsAg-negative/HBV DNA-negative. Thus, the prevalence of occult HBV infection was 0%. All of the HBsAg-positive patients were anti-HBs-negative/anti-HBc-positive. Of 79 HBsAg-negative patients, 58 (73.4%) were anti-HBs positive and 52 (65.8%) were anti-HBc positive.
CONCLUSIONS: The present study showed that the prevalence of occult HBV infection in chronic hemodialysis patients at our center in Korea was not increased compared to the rates of low endemic regions. Furthermore, occult HBV infection was not a contributing factor in HBV transmission in the hemodialysis unit studied.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19102377

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  9 in total

Review 1.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2019-06-12

Review 2.  KASL clinical practice guidelines: management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

3.  KASL Clinical Practice Guidelines: Management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2012-06-26

Review 4.  Prevalence of occult hepatitis B virus infection.

Authors:  Maria Luisa Gutiérrez-García; Conrado M Fernandez-Rodriguez; Jose Luis Lledo-Navarro; Ingrid Buhigas-Garcia
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

5.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2022-04-01

6.  Epidemiology of occult hepatitis B infection among thalassemic, hemophilia, and hemodialysis patients.

Authors:  Mohammad Kazemi Arababadi; Behzad Nasiri Ahmadabadi; Hassan Yousefi Daredor; Derek Kennedy
Journal:  Hepat Mon       Date:  2012-05-30       Impact factor: 0.660

7.  Prevalence of occult hepatitis B virus infection in hemodialysis patients from egypt with or without hepatitis C virus infection.

Authors:  Mona A Abu El Makarem; Mohammed Abdel Hamid; Ashraf Abdel Aleem; Ahmed Ali; Mohammed Shatat; Douaa Sayed; Ali Deaf; Lamia Hamdy; Effat A Tony
Journal:  Hepat Mon       Date:  2012-04-30       Impact factor: 0.660

8.  Hepatitis B virus Genotyping Among Patients With Cirrhosis.

Authors:  Nastaran Ansari; Manochehr Makvandi; Ali Reza Samarbaf-Zadeh
Journal:  Jundishapur J Microbiol       Date:  2015-01-14       Impact factor: 0.747

9.  Prevalence of occult hepatitis B virus infection in hemodialysis patients in Isfahan, Iran.

Authors:  Hamid Kalantari; Faezeh Ferdowsi; Majid Yaran
Journal:  Adv Biomed Res       Date:  2016-09-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.